Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2

Herein, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric binding site (IABS) of CXC chemokine receptor 2 (CXCR2), a G protein-coupled receptor (GPCR) that has been pursued as a drug target in oncology and inflammation. Starting from the cocrysta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2023-07, Vol.66 (14), p.9916-9933
Hauptverfasser: Huber, Max E., Wurnig, Silas, Toy, Lara, Weiler, Corinna, Merten, Nicole, Kostenis, Evi, Hansen, Finn K., Schiedel, Matthias
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9933
container_issue 14
container_start_page 9916
container_title Journal of medicinal chemistry
container_volume 66
creator Huber, Max E.
Wurnig, Silas
Toy, Lara
Weiler, Corinna
Merten, Nicole
Kostenis, Evi
Hansen, Finn K.
Schiedel, Matthias
description Herein, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric binding site (IABS) of CXC chemokine receptor 2 (CXCR2), a G protein-coupled receptor (GPCR) that has been pursued as a drug target in oncology and inflammation. Starting from the cocrystallized intracellular CXCR2 antagonist 00767013 (1), tetramethylrhodamine (TAMRA)-labeled CXCR2 ligands were designed, synthesized, and tested for their suitability as fluorescent reporters to probe binding to the IABS of CXCR2. By means of these studies, we developed Mz438 (9a) as a high-affinity and selective fluorescent CXCR2 ligand, enabling cell-free as well as cellular NanoBRET-based binding studies in a nonisotopic and high-throughput manner. Further, we show that 9a can be used as a tool to visualize intracellular target engagement for CXCR2 via fluorescence microscopy. Thus, our small-molecule-based fluorescent CXCR2 ligand 9a represents a promising tool for future studies of CXCR2 pharmacology.
doi_str_mv 10.1021/acs.jmedchem.3c00769
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10388362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2839739387</sourcerecordid><originalsourceid>FETCH-LOGICAL-a450t-faced7b6f997cdf4b0247c59a39b09c83386dcadeb0532ee926d4d8ab09eed563</originalsourceid><addsrcrecordid>eNp9UU1v1DAUtBCILlv-AUI-csnWsfPlEypRC5VWQuqHxM1y7JesS2IvtlOJK78cp7utyoWTZb2ZefNmEPqQk01OaH4mVdjcT6DVDqYNU4TUFX-FVnlJSVY0pHiNVoRQmtGKshP0LoR7QgjLKXuLTlhdVKzg1Qr9uRxn5yEosBFvzSCtDvjCym4EfCv9ADH9BjnAtABu4qwNBNw7j-MO8JWNXioYx3mUHp-PowsRvFH4i7Ha2AHfmAjY9Y_gNhl1P40FfA0K9jFptD_aa3qK3vRyDPD--K7R3eXFbfst237_etWebzNZlCRmfVqk667qOa-V7ouO0KJWJZeMd4SrhrGm0kpq6EjJKACnlS50I9MQQJcVW6PPB9393C25wWJ-FHtvJul_CyeN-HdizU4M7kHkhDUNSzGu0aejgne_ZghRTCYs50sLbg6CNozXjLOmTtDiAFXeheChf96TE7H0J1J_4qk_cewv0T6-9PhMeiosAcgB8Eh3s7cpsv9r_gX0Kq4M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2839739387</pqid></control><display><type>article</type><title>Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Huber, Max E. ; Wurnig, Silas ; Toy, Lara ; Weiler, Corinna ; Merten, Nicole ; Kostenis, Evi ; Hansen, Finn K. ; Schiedel, Matthias</creator><creatorcontrib>Huber, Max E. ; Wurnig, Silas ; Toy, Lara ; Weiler, Corinna ; Merten, Nicole ; Kostenis, Evi ; Hansen, Finn K. ; Schiedel, Matthias</creatorcontrib><description>Herein, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric binding site (IABS) of CXC chemokine receptor 2 (CXCR2), a G protein-coupled receptor (GPCR) that has been pursued as a drug target in oncology and inflammation. Starting from the cocrystallized intracellular CXCR2 antagonist 00767013 (1), tetramethylrhodamine (TAMRA)-labeled CXCR2 ligands were designed, synthesized, and tested for their suitability as fluorescent reporters to probe binding to the IABS of CXCR2. By means of these studies, we developed Mz438 (9a) as a high-affinity and selective fluorescent CXCR2 ligand, enabling cell-free as well as cellular NanoBRET-based binding studies in a nonisotopic and high-throughput manner. Further, we show that 9a can be used as a tool to visualize intracellular target engagement for CXCR2 via fluorescence microscopy. Thus, our small-molecule-based fluorescent CXCR2 ligand 9a represents a promising tool for future studies of CXCR2 pharmacology.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.3c00769</identifier><identifier>PMID: 37463496</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Allosteric Site ; Ligands ; Protein Binding ; Receptors, G-Protein-Coupled - metabolism ; Receptors, Interleukin-8B</subject><ispartof>Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9916-9933</ispartof><rights>2023 The Authors. Published by American Chemical Society</rights><rights>2023 The Authors. Published by American Chemical Society 2023 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a450t-faced7b6f997cdf4b0247c59a39b09c83386dcadeb0532ee926d4d8ab09eed563</citedby><cites>FETCH-LOGICAL-a450t-faced7b6f997cdf4b0247c59a39b09c83386dcadeb0532ee926d4d8ab09eed563</cites><orcidid>0000-0001-8284-5514 ; 0000-0001-6932-2217 ; 0000-0001-7365-3617 ; 0009-0009-6708-7415 ; 0009-0006-7809-1426 ; 0000-0002-8487-6805 ; 0000-0003-3042-0463 ; 0000-0001-9765-5975</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00769$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00769$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37463496$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huber, Max E.</creatorcontrib><creatorcontrib>Wurnig, Silas</creatorcontrib><creatorcontrib>Toy, Lara</creatorcontrib><creatorcontrib>Weiler, Corinna</creatorcontrib><creatorcontrib>Merten, Nicole</creatorcontrib><creatorcontrib>Kostenis, Evi</creatorcontrib><creatorcontrib>Hansen, Finn K.</creatorcontrib><creatorcontrib>Schiedel, Matthias</creatorcontrib><title>Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Herein, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric binding site (IABS) of CXC chemokine receptor 2 (CXCR2), a G protein-coupled receptor (GPCR) that has been pursued as a drug target in oncology and inflammation. Starting from the cocrystallized intracellular CXCR2 antagonist 00767013 (1), tetramethylrhodamine (TAMRA)-labeled CXCR2 ligands were designed, synthesized, and tested for their suitability as fluorescent reporters to probe binding to the IABS of CXCR2. By means of these studies, we developed Mz438 (9a) as a high-affinity and selective fluorescent CXCR2 ligand, enabling cell-free as well as cellular NanoBRET-based binding studies in a nonisotopic and high-throughput manner. Further, we show that 9a can be used as a tool to visualize intracellular target engagement for CXCR2 via fluorescence microscopy. Thus, our small-molecule-based fluorescent CXCR2 ligand 9a represents a promising tool for future studies of CXCR2 pharmacology.</description><subject>Allosteric Site</subject><subject>Ligands</subject><subject>Protein Binding</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>Receptors, Interleukin-8B</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1v1DAUtBCILlv-AUI-csnWsfPlEypRC5VWQuqHxM1y7JesS2IvtlOJK78cp7utyoWTZb2ZefNmEPqQk01OaH4mVdjcT6DVDqYNU4TUFX-FVnlJSVY0pHiNVoRQmtGKshP0LoR7QgjLKXuLTlhdVKzg1Qr9uRxn5yEosBFvzSCtDvjCym4EfCv9ADH9BjnAtABu4qwNBNw7j-MO8JWNXioYx3mUHp-PowsRvFH4i7Ha2AHfmAjY9Y_gNhl1P40FfA0K9jFptD_aa3qK3vRyDPD--K7R3eXFbfst237_etWebzNZlCRmfVqk667qOa-V7ouO0KJWJZeMd4SrhrGm0kpq6EjJKACnlS50I9MQQJcVW6PPB9393C25wWJ-FHtvJul_CyeN-HdizU4M7kHkhDUNSzGu0aejgne_ZghRTCYs50sLbg6CNozXjLOmTtDiAFXeheChf96TE7H0J1J_4qk_cewv0T6-9PhMeiosAcgB8Eh3s7cpsv9r_gX0Kq4M</recordid><startdate>20230727</startdate><enddate>20230727</enddate><creator>Huber, Max E.</creator><creator>Wurnig, Silas</creator><creator>Toy, Lara</creator><creator>Weiler, Corinna</creator><creator>Merten, Nicole</creator><creator>Kostenis, Evi</creator><creator>Hansen, Finn K.</creator><creator>Schiedel, Matthias</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8284-5514</orcidid><orcidid>https://orcid.org/0000-0001-6932-2217</orcidid><orcidid>https://orcid.org/0000-0001-7365-3617</orcidid><orcidid>https://orcid.org/0009-0009-6708-7415</orcidid><orcidid>https://orcid.org/0009-0006-7809-1426</orcidid><orcidid>https://orcid.org/0000-0002-8487-6805</orcidid><orcidid>https://orcid.org/0000-0003-3042-0463</orcidid><orcidid>https://orcid.org/0000-0001-9765-5975</orcidid></search><sort><creationdate>20230727</creationdate><title>Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2</title><author>Huber, Max E. ; Wurnig, Silas ; Toy, Lara ; Weiler, Corinna ; Merten, Nicole ; Kostenis, Evi ; Hansen, Finn K. ; Schiedel, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a450t-faced7b6f997cdf4b0247c59a39b09c83386dcadeb0532ee926d4d8ab09eed563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Allosteric Site</topic><topic>Ligands</topic><topic>Protein Binding</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>Receptors, Interleukin-8B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huber, Max E.</creatorcontrib><creatorcontrib>Wurnig, Silas</creatorcontrib><creatorcontrib>Toy, Lara</creatorcontrib><creatorcontrib>Weiler, Corinna</creatorcontrib><creatorcontrib>Merten, Nicole</creatorcontrib><creatorcontrib>Kostenis, Evi</creatorcontrib><creatorcontrib>Hansen, Finn K.</creatorcontrib><creatorcontrib>Schiedel, Matthias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huber, Max E.</au><au>Wurnig, Silas</au><au>Toy, Lara</au><au>Weiler, Corinna</au><au>Merten, Nicole</au><au>Kostenis, Evi</au><au>Hansen, Finn K.</au><au>Schiedel, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2023-07-27</date><risdate>2023</risdate><volume>66</volume><issue>14</issue><spage>9916</spage><epage>9933</epage><pages>9916-9933</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Herein, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric binding site (IABS) of CXC chemokine receptor 2 (CXCR2), a G protein-coupled receptor (GPCR) that has been pursued as a drug target in oncology and inflammation. Starting from the cocrystallized intracellular CXCR2 antagonist 00767013 (1), tetramethylrhodamine (TAMRA)-labeled CXCR2 ligands were designed, synthesized, and tested for their suitability as fluorescent reporters to probe binding to the IABS of CXCR2. By means of these studies, we developed Mz438 (9a) as a high-affinity and selective fluorescent CXCR2 ligand, enabling cell-free as well as cellular NanoBRET-based binding studies in a nonisotopic and high-throughput manner. Further, we show that 9a can be used as a tool to visualize intracellular target engagement for CXCR2 via fluorescence microscopy. Thus, our small-molecule-based fluorescent CXCR2 ligand 9a represents a promising tool for future studies of CXCR2 pharmacology.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>37463496</pmid><doi>10.1021/acs.jmedchem.3c00769</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-8284-5514</orcidid><orcidid>https://orcid.org/0000-0001-6932-2217</orcidid><orcidid>https://orcid.org/0000-0001-7365-3617</orcidid><orcidid>https://orcid.org/0009-0009-6708-7415</orcidid><orcidid>https://orcid.org/0009-0006-7809-1426</orcidid><orcidid>https://orcid.org/0000-0002-8487-6805</orcidid><orcidid>https://orcid.org/0000-0003-3042-0463</orcidid><orcidid>https://orcid.org/0000-0001-9765-5975</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9916-9933
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10388362
source MEDLINE; American Chemical Society Journals
subjects Allosteric Site
Ligands
Protein Binding
Receptors, G-Protein-Coupled - metabolism
Receptors, Interleukin-8B
title Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A38%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluorescent%20Ligands%20Enable%20Target%20Engagement%20Studies%20for%20the%20Intracellular%20Allosteric%20Binding%20Site%20of%20the%20Chemokine%20Receptor%20CXCR2&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Huber,%20Max%20E.&rft.date=2023-07-27&rft.volume=66&rft.issue=14&rft.spage=9916&rft.epage=9933&rft.pages=9916-9933&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.3c00769&rft_dat=%3Cproquest_pubme%3E2839739387%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2839739387&rft_id=info:pmid/37463496&rfr_iscdi=true